0000059478-21-000026.txt : 20210203 0000059478-21-000026.hdr.sgml : 20210203 20210203184314 ACCESSION NUMBER: 0000059478-21-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Neill Myles CENTRAL INDEX KEY: 0001725140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 21587947 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 4 1 wf-form4_161239577477766.xml FORM 4 X0306 4 2021-02-01 0 0000059478 ELI LILLY & Co LLY 0001725140 O'Neill Myles LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 0 1 0 0 SVP & Pres., Mfg. Operations Common Stock 2021-02-01 4 M 0 12146 0 A 56919 D Common Stock 2021-02-01 4 F 0 5438 207.97 D 51481 D Common Stock 1921 I 401(k) Common Stock 8469 I by spouse Restricted Stock Unit 2021-02-01 4 M 0 12146 0 D 2021-02-01 2021-02-01 Common Stock 12146.0 0 D Reporting person disclaims beneficial ownership of these shares. Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Crystal T. Williams for Myles O'Neill, authorization on file 2021-02-03 EX-24 2 ex-24.htm O'NEILL_POA

Myles O'Neill
Lilly Corporate Center
Indianapolis, Indiana 46285

Securities and Exchange Commission
Washington, D.C. 20549

Authorization Regarding Reporting Forms

I hereby authorize and designate the following persons to sign and file with the Commission on my behalf Forms 3, 4, and 5(including any amendments thereto) covering my transactions and holdings in the common stock and other equity securities of Eli Lilly and Company as required by Section 16 of the Securities Exchange Act of 1934 and the rules thereunder:

     Anat Hakim, Lilly Corporate Center, Indianapolis, Indiana

     Crystal T. Williams, Lilly Corporate Center, Indianapolis, Indiana

     Erin Conway, Lilly Corporate Center, Indianapolis, Indiana

This authorization and designation shall remain in effect until a written revocation is signed by me and provided to the Commission.

Date: December 11, 2020



/s/ Myles O'Neill